(Q38322338)

2 September 2017

1 reference

title

Genomic medicine and risk prediction across the disease spectrum (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Armand Peeters

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Nicki Tiffin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Johann Schneider

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

Nicole van der Merwe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

13

Fredrieka M Pienaar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

21

Juanita Bezuidenhout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Susan Janse van Rensburg

14

object named as

Susan J van Rensburg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

17

Kelebogile E Moremi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Hilmar K Lückhoff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Karin Baatjes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mardelle Schoeman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Lize van der Merwe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Kathleen A Grant

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Leslie R Fisher

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jacobus Pretorius

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

David P van Velden

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ettienne J Myburgh

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Yandiswa Y Yako

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Alison V September

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Frans J Cronje

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Christianne S H Bouwens

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Justus P Apffelstaedt

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

F Stephen Hough

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Rajiv T Erasmus

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

1 reference

19 January 2015

1 reference

Critical Reviews in Clinical Laboratory Sciences

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

120-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25597499%20AND%20SRC:MED&resulttype=core&format=json

Measuring the global burden of disease

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Genome-based prediction of common diseases: advances and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Systems biology and p4 medicine: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Huntington's disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The evidence dilemma in genomic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The challenge of implementing genetic tests with clinical utility while avoiding unsound applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Pathology-supported genetic testing directed at shared disease pathways for optimized health in later life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

A pathway-based view of human diseases and disease relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Prioritising risk pathways of complex human diseases based on functional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Computational neuroanatomy of speech production.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Redefining heart failure: the utility of genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The impact of genetics and genomics on public health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Implementation of a breast cancer genetic service in South Africa - lessons learned.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

MammaPrint Pre-screen Algorithm (MPA) reduces chemotherapy in patients with early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Impaired tamoxifen metabolism reduces survival in familial breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Heterogeneity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Metabolic syndrome and triple-negative breast cancer: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Long-term impact of the 70-gene signature on breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

HER2 testing: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The metabolic syndrome and development of cognitive impairment among older women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Metabolic syndrome as a risk factor for neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Metabolic syndrome meets osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Hyperuricemia, gout and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Association of nephrolithiasis with metabolic syndrome and its components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Obstructive sleep apnea, inflammation, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Higher incidence of mild cognitive impairment in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Pharmacogenomics and therapeutic prospects in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Potential biomarkers in psychiatry: focus on the cholesterol system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

CYP2D6*4 polymorphism is associated with statin-induced muscle effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Statistical analysis strategies for association studies involving rare variants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Inflated type I error rates when using aggregation methods to analyze rare variants in the 1000 Genomes Project exon sequencing data in unrelated individuals: summary results from Group 7 at Genetic Analysis Workshop 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Analysis of viral and genetic factors in South African patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Iron status in children with recurrent episodes of tumefactive cerebral demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Complete genome phasing of family quartet by combination of genetic, physical and population-based phasing analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

The biobank as an ethical subject

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Population-specific common SNPs reflect demographic histories and highlight regions of genomic plasticity with functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Self-guided management of exome and whole-genome sequencing results: changing the results return model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Clinical assessment incorporating a personal genome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Whole genome sequencing in support of wellness and health maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930

Metabolic syndrome and the risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2014.997930